Matrix metalloproteinase 2 (MMP2) protein expression and laryngeal cancer prognosis: a meta analysis
- PMID: 25932160
- PMCID: PMC4402807
Matrix metalloproteinase 2 (MMP2) protein expression and laryngeal cancer prognosis: a meta analysis
Abstract
Objective: To investigate the protein expression of matrix metalloproteinase 2 (MMP2) and its clinical significance in laryngeal cancer.
Methods: A comprehensive search for the related literature published in China and other countries was conducted in a variety of databases, including MEDLINE, Embase, China Academic Journals Full-text Database, Wanfang Data and VIP Database. A total of seven case-control studies were included in the final systematic assessment. A meta-analysis software program was used to statistically analyze the raw data from each study for the calculation of the pooled odds ratio (OR) and 95% confidence interval (95% CI).
Results: The meta-analysis indicated that, compared with normal laryngeal tissue, the MMP2 protein was highly expressed in the laryngeal cancer tissue [OR=21.67; 95% CI: 11.61-40.43; P<0.001]. Compared with highly differentiated laryngeal cancer, the MMP2 protein expression level was higher in the moderately and poorly differentiated laryngeal cancers [OR=0.25; 95% CI: 0.13-0.46; P<0.001]. Compared with laryngeal cancers without lymph node metastasis, the laryngeal cancers with lymph node metastasis exhibited a greatly elevated MMP2 protein expression [OR=0.25; 95% CI: 0.14-0.46; P<0.001].
Conclusion: High protein expression levels of MMP2 may play an important role in the tumorigenesis, progression and prognosis of laryngeal cancer.
Keywords: Laryngeal cancer; matrix metalloproteinase 2 (MMP2); meta-analysis.
Figures




Similar articles
-
Prognostic significance of the immunoexpression of matrix metalloproteinase MMP2 and its inhibitor TIMP2 in laryngeal cancer.Med Sci Monit. 2003 Mar;9(3):MT42-7. Med Sci Monit. 2003. PMID: 12640351
-
Pathological and prognostic significance of matrix metalloproteinase-2 expression in ovarian cancer: a meta-analysis.Clin Exp Med. 2016 Aug;16(3):375-82. doi: 10.1007/s10238-015-0369-y. Epub 2015 Jun 30. Clin Exp Med. 2016. PMID: 26123901
-
Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.Gene. 2013 Mar 15;517(1):65-71. doi: 10.1016/j.gene.2012.12.085. Epub 2013 Jan 9. Gene. 2013. PMID: 23313298
-
Relationships between abnormal MMP2 expression and prognosis in gastric cancer: a meta-analysis of cohort studies.Cancer Biother Radiopharm. 2014 May;29(4):166-72. doi: 10.1089/cbr.2014.1608. Epub 2014 Apr 30. Cancer Biother Radiopharm. 2014. PMID: 24784911 Review.
-
The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases.Onco Targets Ther. 2017 Jul 3;10:3261-3276. doi: 10.2147/OTT.S135593. eCollection 2017. Onco Targets Ther. 2017. PMID: 28740401 Free PMC article. Review.
Cited by
-
Physical exercise modulates the level of serum MMP-2 and MMP-9 in patients with breast cancer.Oncol Lett. 2016 Sep;12(3):2119-2126. doi: 10.3892/ol.2016.4887. Epub 2016 Jul 20. Oncol Lett. 2016. PMID: 27602150 Free PMC article.
-
Inhibition of PLK4 might enhance the anti-tumour effect of bortezomib on glioblastoma via PTEN/PI3K/AKT/mTOR signalling pathway.J Cell Mol Med. 2020 Apr;24(7):3931-3947. doi: 10.1111/jcmm.14996. Epub 2020 Mar 3. J Cell Mol Med. 2020. PMID: 32126150 Free PMC article.
-
Tapirira guianensis Aubl. Extracts Inhibit Proliferation and Migration of Oral Cancer Cells Lines.Int J Mol Sci. 2016 Nov 8;17(11):1839. doi: 10.3390/ijms17111839. Int J Mol Sci. 2016. PMID: 27834805 Free PMC article.
-
Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis.BMC Pulm Med. 2020 Oct 28;20(1):283. doi: 10.1186/s12890-020-01317-1. BMC Pulm Med. 2020. PMID: 33115469 Free PMC article.
-
The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma.Sci Rep. 2021 Sep 14;11(1):18228. doi: 10.1038/s41598-021-97648-y. Sci Rep. 2021. PMID: 34521883 Free PMC article.
References
-
- Braakhuis BJ, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014;50:670–5. - PubMed
-
- Colović Z, Pesutić-Pisac V, Poljak NK, Racić G, Cikojević D, Kontić M. Expression of matrix metalloproteinase-9 in patients with squamous cell carcinoma of the larynx. Coll Antropol. 2013;37:151–5. - PubMed
-
- Bodnar M, Szylberg L, Kazmierczak W, Marszalek A. Differentiated expression of membrane type metalloproteinases (MMP-14, MMP-15) and pro-MMP2 in laryngeal squamous cell carcinoma. A novel mechanism. J Oral Pathol Med. 2013;42:267–74. - PubMed
-
- Bauvois B. New facets of matrix metalloprotienases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 2012;1825:29–36. - PubMed
-
- Uloza V, Liutkevičius V, Pangonytė D, Saferis V, Lesauskaitė V. Expression of matrix metalloproteinases (MMP-2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels. Eur Arch Otorhinolaryngol. 2011;268:871–8. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous